Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Table 11

Analysis of the change of eGFR in pre- and post-treatment.

Variable	Treatment group	Control group	Statistics	value
Change			7.40 (grouped T-test)	<0.0001
N (missing)	149 (1)	148 (2)
Mean ± SD (ml/min/1.73 m^2)	17.95 ± 21.86	0.04 ± 19.83
Median (ml/min/1.73 m^2)	17.93	−0.72
Min-max (ml/min/1.73 m^2)	−33.85–88.97	−58.75–63.27